Menu Search
Equities

Alignment Healthcare Inc

ALHC:NSQ

Alignment Healthcare Inc

Actions
Health CareHealth Care Providers
  • Price (USD)12.78
  • Today's Change-0.38 / -2.89%
  • Shares traded934.14k
  • 1 Year change+110.54%
  • Beta1.4546
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Alignment Healthcare Inc grew revenues 27.16% from 1.43bn to 1.82bn while net income improved from a loss of 149.55m to a smaller loss of 148.02m.
Gross margin10.45%
Net profit margin-5.85%
Operating margin-4.90%
Return on assets-19.72%
Return on equity-95.13%
Return on investment-41.65%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Alignment Healthcare Inc fell by 206.35m. Cash Flow from Financing totalled 105.00k or 0.01% of revenues. In addition the company used 59.19m for operations while cash used for investing totalled 147.26m.
Cash flow per share-0.622
Price/Cash flow per share--
Book value per share0.5979
Tangible book value per share0.3924
More ▼

Balance sheet in USDView more

Alignment Healthcare Inc has a Debt to Total Capital ratio of 64.71%, a lower figure than the previous year's 85.73%.
Current ratio1.60
Quick ratio--
Total debt/total equity1.85
Total debt/total capital0.6471
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.